197

Drug Discovery
Sub Categories on Drug Discovery
{{items.name}}
Latest Articles
Weekly Update of Drug News-2/12/2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for
Updated on: December 02,2025 0
Weekly Update of Drug News-2/12/2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for
Updated on:December 02,2025 0
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com